A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation
2020 · Genome biology · 51 citations
https://doi.org/10.1186/s13059-020-02150-9
B
Baokun Sui
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
553
Citations
13
h-index
18
i10-index
Baokun Sui is an academic researcher from Huazhong Agricultural University. The author has contributed to research in topics: Rabies epidemiology and control & Toxoplasma gondii Research Studies & Viral Infections and Outbreaks Research. The author has an h-index of 13, co-authored 29 publications.
ORCID: 0000-0003-2738-5804Papers by this author
worksSubstitution of S179P in the Lyssavirus Phosphoprotein Impairs Its Interferon Antagonistic Function
2022 · Journal of Virology · 12 citations
https://doi.org/10.1128/jvi.01125-22
TRIM72 restricts lyssavirus infection by inducing K48-linked ubiquitination and proteasome degradation of the matrix protein
2024 · PLoS Pathogens · 7 citations
https://doi.org/10.1371/journal.ppat.1011718
The CH24H metabolite, 24HC, blocks viral entry by disrupting intracellular cholesterol homeostasis
2023 · Redox Biology · 6 citations
https://doi.org/10.1016/j.redox.2023.102769
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1
2025 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-025-66018-x
Additional file 2 of A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12904899
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat